Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Treatment.com AI Inc TREIF


Primary Symbol: C.TRUE

Healthcare Medical Devices
Treatment.com AI Inc., through its wholly owned subsidiary, Treatment.com Inc., is in the business of providing personalized health care information. The Company has developed a personalized healthcare artificial intelligence (AI) engine, the Global Library of Medicine (GLM), which is engaged in providing clinical information and support to all healthcare professionals. The GLM delivers over 92... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:TRUE)

Repeat: Treatment.com AI Announces New Additions to its Medical Education Suite (MES)

GlobeNewswire 8 days ago

Treatment.com AI Announces New Additions to its Medical Education Suite (MES)

GlobeNewswire 8 days ago

Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)

GlobeNewswire April 10, 2024

Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption

GlobeNewswire April 8, 2024

Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity

GlobeNewswire March 27, 2024

Treatment AI Passes Medical School Clinical Exam with 92% Success Rate

GlobeNewswire March 20, 2024

TREATMENT.COM AI INC. CLOSES OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT OF $2,908,200

GlobeNewswire March 14, 2024

Treatment.com AI Provides Corporate Update

GlobeNewswire February 29, 2024

TREATMENT.COM AI INC. APPOINTS CHIEF FINANCIAL OFFICER

GlobeNewswire February 7, 2024
View More News ››

Opinion & Analysis (CSE:TRUE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:TRUE)

CSE: $TRUE .60 x .66 Thin to .70+

Treatment AI Passes Medical School Clinical Exam with 92% Success Rate https://finance.yahoo.com/news/treatment-ai-passes-medical-school...
MasterJedijazz - April 5, 2024

$TRUE Looks like the CEO bought some shares on open market

$TRUE Looks like the CEO bought some shares on the open market Canadian side. I always watch for form 4 filings on the US market but this...
FINALCUT71 - April 4, 2024

Ready for a bullish run! CSE: TRUE Treatment.com AI

OTC: $TREIF CSE: $TRUE Our (GLM) #AI system can support better health decisions for patients, more efficient & effective doctor...
MasterJedijazz - April 4, 2024

CSE: $TRUE A revolutionary new application of AI OTC: $TREIF

OTC: $TREIF CSE: $TRUE A revolutionary new application of medical AI, through the proprietary Global Library of Medicine (GLM) has...
MasterJedijazz - April 3, 2024

$TRUE Currently up 8% and spread has tightened up nicely.

Spread currently at .46 X .60 on 12K volume. Average 10 day volume of 8K so significantly over that mark. 15 Million on the float so...
FINALCUT71 - April 2, 2024

OTC: $TREIF .4992 +13.88% CSE: $TRUE .67 +6.3% #BULLISH

OTC: $TREIF .4992 +13.88% CSE: $TRUE .67 +6.3% #BULLISH Treatment AI Passes Medical School Clinical Exam with 92% Success Rate ; Dr...
MasterJedijazz - April 2, 2024
View more Bullboard ››

Ucore Rare Metals Inc.

Ucore Rare Metals Inc.

Ucore is focused on rare and critical-metal resources, extraction, beneficiation, and separation technologies with the ...
View More »